Although BAL is an important diagnostic tool (Davison et al. 1983; Dodson et al. 1991; Rom et al. 2002), it is an invasive procedure unsuitable for screening or repeated follow-up evaluations after exposure to dusts or combustion/pyrolysis products.
Current practices do not contribute to scientific progress because the data from the procedures are unsuitable for follow-up research to measure outcomes.
This procedure is unsuitable for formalin-fixed needle biopsy specimens because, following dewaxing, the tiny specimens are easily lost and very difficult to orientate and re-embed vertically.
Furthermore, their high cost and lengthy installation procedures make them unsuitable for deployment in remote locations and emergency scenarios.
Some CAM practitioners maintain that the assumptions underlying CAM treatment and procedures make it unsuitable for conventional scientific assessment.
Extensive scar tissue, binding the skin to the bone, may obviously render the procedure unsuitable.
Results indicated that Walraven function is unsuitable for ASTM.
These methods are also time-consuming because they have complex handling procedures; thus, they are unsuitable for on-site rapid screening detection of AFB1.
Patients suitable for procedure are given their date and patients unsuitable for the procedure are placed on the correct pathway.
